A phase III trial of amitriptyline/ketamine in patients with chemotherapy-induced peripheral neuropathies who have previously received taxane-based chemotherapy.

Trial Profile

A phase III trial of amitriptyline/ketamine in patients with chemotherapy-induced peripheral neuropathies who have previously received taxane-based chemotherapy.

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 10 Apr 2014

At a glance

  • Drugs Amitriptyline/ketamine (Primary) ; Amitriptyline; Ketamine
  • Indications Neuropathic pain
  • Focus Registrational; Therapeutic Use
  • Sponsors Immune Pharmaceuticals Inc
  • Most Recent Events

    • 10 Apr 2014 Planned initiation date changed from 1 Dec 2012 to unknown (licensing partner is being sought).
    • 28 Dec 2011 Status changed from planning to not yet recruiting.
    • 12 Nov 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top